Validated HPLC and HPTLC Methods for the Determination of Agomelatine in Bulk and Tablets | ||
| Egyptian Journal of Chemistry | ||
| Article 37, Volume 64, Issue 2, February 2021, Pages 957-969 PDF (488.14 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejchem.2020.42028.2845 | ||
| Authors | ||
| Hala Labib1; Hytham Ahmed* 2; Yousef Elshamy3; Wael Talaat4; Tarek Belal5 | ||
| 1Department of Pharmaceutical Chemistry, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt | ||
| 2Menoufia University | ||
| 3Pharmaceutical Chemistry Department, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt | ||
| 4Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Damanhour University, Damanhour 25511, Egypt | ||
| 5Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt | ||
| Abstract | ||
| The present study represents validated simple, rapid and reliable chromatographic methods for analysis of the antidepressant drug agomelatine (AGO) in bulk powder and in tablet dosage form. Method I involved application of RP-HPLC with diode array detection where Agilent Zorbax Eclipse-C18 column (4.6 × 150 mm, 5 μm) was used as stationary phase at ambient temperature (25±5). The mobile phase was composed of phosphate buffer (0.05 M, pH 3) and acetonitrile in the ratio 60:40 (v/v) and was pumped isocratically at 1 mL/min. In method II, HPTLC plates (20 × 10 cm, aluminum plates with 250-μm thickness precoated with silica gel 60 F254) was used as stationary phase with mobile phase composed of chloroform: methanol (9.3: 0.7, v/v). Detection was carried out at 230 nm in both methods. The structurally related melatonin was used as internal standard (IS) in both methods. The developed methods were validated according to International Conference of Harmonization (ICH) guidelines with respect to linearity, ranges, accuracy, precision, robustness and limits of detection and quantitation. Linearity ranges were 0.5-3 μg/mL and 25-200 ng/spot in method I and method II respectively. Limits of detection and quantitation were 0.081 and 0.25 μg/mL for method I and 4.65 and 14.11 ng/spot for method II, respectively. Intra and inter-day precision were verified by the RSD% values which were less than 2%. The methods were implemented for assay of AGO tablet dosage form with no observable interferences. | ||
| Keywords | ||
| HPLC; HPTLC; Agomelatine; Bulk; Tablets; validation | ||
|
Statistics Article View: 665 PDF Download: 543 |
||
